account_balance
Investment manager · 13F filer · SEC CIK 1762304
HHLR Advisors, Ltd.
Reported value$832Mas of Jun 30, 2026
Positions35 6 new, 9 sold out
Top 10 weight85.7%LEGN alone is 21%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
LEGNLegend Biotech Corp
20.8%
FUTUFutu Hldgs Ltd
19.9%Added +25%
AVBPArrivent Biopharma Inc
16.4%
MRVLMarvell Technology Inc
5.8%Trimmed −5%
VIPSVipshop Hldgs Ltd
5.5%Added +2683%
PDDPDD Holdings Inc
4.6%Trimmed −88%
BEKEKe Hldgs Inc
3.9%Trimmed −48%
CTKBCytek Biosciences Inc
3.5%
ALMRAlamar Biosciences Inc
3.1%New
BABA2.1%ODTX1.9%YSG1.9%LEGNLegend Biotech Corp
20.8%
FUTUFutu Hldgs Ltd
19.9%Added +25%
AVBP16.4%MRVL5.8%VIPS5.5%PDD4.6%BEKE3.9%CTKB3.5%ALMR3.1%BABAODTXYSGBoxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
LEGN Legend Biotech Corp 20.8% HeldFUTU Futu Hldgs Ltd 19.9% Added +25%AVBP Arrivent Biopharma Inc 16.4% HeldMRVL Marvell Technology Inc 5.8% Trimmed −5%VIPS Vipshop Hldgs Ltd 5.5% Added +2683%PDD PDD Holdings Inc 4.6% Trimmed −88%BEKE Ke Hldgs Inc 3.9% Trimmed −48%CTKB Cytek Biosciences Inc 3.5% HeldALMR Alamar Biosciences Inc 3.1% NewBABA Alibaba Group HLDG Ltd 2.1% Trimmed −93%ODTX Odyssey Therapeutics Inc 1.9% NewYSG Yatsen HLDG Ltd 1.9% Held
What changed